The autoregulatory serglycin/CD44 axis drives stemness‐like phenotypes in TNBC in a β‐catenin‐dependent manner

• Li Cao,
• Fei‐Fei Luo,
• Hong‐Bin Huang,
• Tie‐Jun Huang,
• Hao Hu,
• Li‐Sheng Zheng,
• Jing Wang,
• Li‐Xia Peng,
• Chao‐Nan Qian,
• Bi‐Jun Huang

Affiliations

Li Cao

School of Pharmaceutical Science Sun Yat‐sen University Guangzhou People's Republic of China

Fei‐Fei Luo

State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou People's Republic of China

Hong‐Bin Huang

Department of Pharmacy Sun Yat‐Sen University Cancer Center Guangzhou People's Republic of China

Tie‐Jun Huang

Department of Nuclear Medicine The Second People's Hospital of Shenzhen Shenzhen People's Republic of China

Hao Hu

Department of Traditional Chinese Medicine The First Affiliated Hospital of Sun Yat‐Sen University Guangzhou People's Republic of China

Li‐Sheng Zheng

State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou People's Republic of China

Jing Wang

State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou People's Republic of China

Li‐Xia Peng

State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou People's Republic of China

Chao‐Nan Qian

State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou People's Republic of China

Bi‐Jun Huang

State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou People's Republic of China